Drugmakers in late stages of several possible Alzheimer's drugs

Several drugs in late-stage trials are showing potential as treatments for Alzheimer's disease, some of them originally intended for other diseases. Drugmakers behind the trials say they expect to apply to the FDA within the next few years for a variety of solutions, including a prostate-cancer drug, a diabetes drug and one derived from an old class of anti-inflammatory drugs. Other trials of such treatments as statins and antibodies also are showing promise.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA